Milane et al. synthesized an EGFR-targeted paclitaxel/lonidamine co-loaded PLGA/PEG/EGFR targeting peptide combined poly(ε-caprolactone) NPs for the treatment of MDR breast tumor cells. This evidence concerns the gene EGFR and breast neoplasm.